Ozempic & Wegovy Linked to Serious Eye Condition: NAION. Were You Affected?

If you experienced sudden vision loss after using Ozempic, Wegovy, Saxenda, or Victoza, you may have developed NAION - a serious condition that can cause permanent blindness.

Check if you qualify for compensation

Ozempic®, Wegovy®, and Rybelsus® are registered trademarks of Novo Nordisk A/S. This website is not affiliated with, sponsored by, or endorsed by Novo Nordisk.

Request Your Free Claim Consultation!




By clicking the “Submit My Claim” button, you certify that you have provided your legal name and your own phone number, you agree to the Terms and Conditions and Privacy Policy and authorize Lawsuit Claims and its partners to contact you by email or at the phone number you entered using automated technology including recurring auto-dialers, pre-recorded messages, and text messages, even if your phone is a mobile number or is currently listed on any state, federal, or corporate “Do Not Call” list. You understand that your telephone company may impose charges on you for these contacts, and that you can revoke this consent at any time. For SMS campaigns Text STOP to cancel and HELP for help. Message and data rates may apply. By clicking the “Submit My Claim” button and submitting this form, I affirm that I have read and agree to this Site’s Terms and Conditions (including the arbitration provision and the E-SIGN consent) and Privacy Policy.

About

Ozempic, Wegovy, and Rybelsus are diabetes drugs also used for weight loss. Some users have reported serious eye-related side effects, including vision loss.

FDA & Medical Warnings
In June 2022, the FDA flagged serious safety concerns with Ozempic, Wegovy, and similar drugs. Risks include vision loss, NAION, and other severe complications. In May 2023, the National Library of Medicine also reported dangerous side effects. If you've been affected, you may be entitled to compensation.

  • FREE, No-Obligation Consultation
  • Pay Nothing Unless We Win
  • 100% Confidential Case Review
Get Started Today

Serious injuries caused by Ozempic use can include:

NAION (Non-arteritic Anterior Ischemic Optic Neuropathy)

NAION is a serious eye condition that can lead to sudden, permanent vision loss. It occurs when blood flow to the optic nerve is disrupted, often without warning.

NAION has been reported in patients using Ozempic and similar medications, and may be linked to the drug's impact on blood vessels and circulation.

Symptoms can include blurred vision, partial vision loss, or a dark area in your field of vision. Immediate medical evaluation is critical.

GET HELP NOW

Eye Stroke

An eye stroke, or retinal artery occlusion, happens when blood flow to the retina is blocked, leading to sudden vision loss.

This condition can be triggered by changes in blood pressure or clotting; both of which may be affected by GLP-1 drugs like Ozempic and Wegovy.

Eye strokes are medical emergencies. If you've experienced sudden vision loss or blurring, seek urgent care and legal guidance.

GET HELP NOW

Sudden Vision Changes

Sudden vision changes — such as blurriness, double vision, or loss of peripheral sight — may be early signs of serious eye damage.

These symptoms have been reported by users of Ozempic, Wegovy, and Rybelsus, and could indicate underlying conditions like NAION or eye stroke.

Don't ignore changes in your vision. Early intervention is key, and you may be entitled to compensation.

GET HELP NOW

Sudden Vision Loss

Sudden vision loss is a frightening and potentially permanent condition. It can occur in one or both eyes and may be linked to GLP-1 medications.

Patients taking Ozempic or similar drugs have reported unexpected and rapid loss of sight, sometimes without pain or warning.

If this has happened to you, it's critical to seek medical and legal help immediately.

GET HELP NOW

DON'T LET YOU OR YOUR FAMILY SUFFER IN SILENCE

We may able to help you pursue compensation to pay for your medical bills.

GET HELP NOW

In The News

Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)

FDA - US Food & Drug Administration

A potentially serious adverse effect of GLP-1 receptor agonists

National Library of Medicine

Woman sues drug-makers of Ozempic and Mounjaro over severe gastrointestinal issues

CNN

Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects

CBS News

Makers of Ozempic and Mounjaro sued over 'stomach paralysis' claims

NBC News

Ozempic, Mounjaro makers hit with ‘stomach paralysis’ lawsuit

NY Post

How It Works

1. Fill out the form to tell us about your case.

2. Get a free legal consultation.

3. Receive potential compensation.